(Q74301350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Eradication of established tumors by CD8+ T cell adoptive immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

L J Old

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H L Hanson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D L Donermeyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J M White

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

V Shankaran

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Shiku

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R D Schreiber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P M Allen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

265-276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

Immunological memory and protective immunity: understanding their relation

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Tumor size at the time of adoptive transfer determines whether tumor rejection occurs

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Adoptive immunotherapy prevents prostate cancer in a transgenic animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Peptide ligand-induced conformation and surface expression of the Ld class I MHC molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Immunotherapeutic approaches to sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

1 reference

7 January 2021

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Tumor rejection antigens of chemically induced sarcomas of inbred mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900026-1

7 January 2021

10.1016/S1074-7613(00)00026-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10981969%20AND%20SRC:MED&resulttype=core&format=json